Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

ECHELON-1 Study Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology